How does personalized medication tie into improving patient experience?

Hovione and Laxxon Medical have partnered for the cGMP production of 3D Screen Printed pharmaceutical applications.

CSO Achim Schneeberger speaks on the development of Laxxon's Levodopa project and the process of Laxxon's technology.

Laxxon Medical is looking at how improving patient experiences for women should be a priority for all medical service providers.

Exploring Patient Safety, Compliance & 3D Screen Printing with Laxxon COO Klaus Kühne

Hovione and Laxxon Medical established an agreement for the cGMP production of 3D screen-printed pharmaceutical applications.

Is digital communication the future of healthcare ? Redpoint Global recently announced the results of a survey conducted by Dynata into...

How Does It Work and How Can It Benefit Patients and Healthcare Providers? When you first hear about the concept of 3D printing of...

New research has discovered a link between non-coding DNA and various neurological disorders.

Join Laxxon's Senior Leadership in this exclusive video interview answering questions about their passions and key milestones.

What does 3D printing medical technology mean for the future of the pharmaceutical industry? The popularity of 3D printing has continued...

Could active pharmaceutical ingredients be the key to generic drug patent issues? Typically, drug manufacturers are protected by a...

How QR Codes Are Revolutionizing The Pharmaceutical Industry QR codes roared into the world in 1994 and were initially used by the...

What threat does counterfeit medicine pose to us? When you pick up your medication from the local pharmacist, getting a legitimate, safe,...

Brand-name drug companies have a limited window to develop, test, trial, and market a product before it becomes available to generic...

Believe it or not, substituting a brand-name drug with a generic drug hasn't always been a choice consumers could make! ‘Generic or brand...